AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DESVENLAFAXINE 50.000 Mg ;
12 registrations across 1 African market— 12 active
Markets with DESVENLAFAXINE 50.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Pristimood Sustained Release Film Coated Tablets | 🇪🇬Egypt | Medizen pharmaceutical industries (Medizen) | active | — |
| DESFAXINATE 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Wadi El Neel Benta for Pharmaceuticals and Medical Devices | active | — |
| bedremine 50mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Venlatrope 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Pristimood Sustained Release Film Coated Tablets | 🇪🇬Egypt | Medizen pharmaceutical industries (Medizen) | active | — |
| Prismaven 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Wellmood Extended Release Film Coated Tablets | 🇪🇬Egypt | Empire Pharma for Pharmaceuticals | active | — |
| DESFAXINATE 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Wadi El Neel Benta for Pharmaceuticals and Medical Devices | active | — |
| bedremine 50mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Prismaven 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Venlatrope 50 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Wellmood Extended Release Film Coated Tablets | 🇪🇬Egypt | Empire Pharma for Pharmaceuticals | active | — |
DESVENLAFAXINE 50.000 Mg ; in Africa — Regulatory Overview
DESVENLAFAXINE 50.000 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.